Investigators talking about Covishield Oxford Vaccine Study @ Jehangir

AstraZeneca Chief Investigator Backs India's 12-16 Week Gap Between Covishield 1st and 2nd JabПодробнее

EBI Public Lecture 2021 - Development of the Oxford AstraZeneca COVID-19 vaccine, Dame Sarah GilbertПодробнее

COVID Conversations: Sarah Gilbert on VaccinesПодробнее

Covid-19 Oxford Vaccine ExplainerПодробнее

AstraZeneca-Oxford vaccine reports 2nd serious adverse event, now what?Подробнее

Oxford's COVID-19 vaccine is highly effective: Phase III trial interim resultsПодробнее

Oxford-AstraZeneca trial data revealedПодробнее

Vaccines | Everything you need to know about the Oxford VaccineПодробнее

Oxford-AstraZeneca trial shows its vaccine is 79% effectiveПодробнее

How Oxford-AstraZeneca Covid Vaccine, Cleared By UK, Works | Coronavirus: Facts vs MythsПодробнее

How the AstraZeneca vaccine measures upПодробнее

Study suggests Oxford-AstraZeneca vaccine effective in over-80s| COVID-19 Vaccine| Latest World NewsПодробнее

US health officials and AstraZeneca hold briefing on Covid vaccine trial – watch liveПодробнее

A doctor answers your AstraZeneca vaccine questionsПодробнее

German patients suspicious about Oxford/AstraZeneca COVID-19 vaccineПодробнее

Why Oxford-AstraZeneca's Covishield Suits India?Подробнее

How Effective Are Pfizer & Covishield (AstraZeneca) Vaccines Against Variant Found In India?Подробнее

UK vaccines dataПодробнее

Oxford AstraZeneca vaccine and blood clot fears: Five key questions answeredПодробнее